HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chien-Tai Ren Selected Research

Globo-H

1/2022Synthesis of Azido-Globo H Analogs for Immunogenicity Evaluation.
12/2014Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigen.
8/2013Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.
2/2013Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer.
8/2008Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chien-Tai Ren Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 08/2008
4Human Influenza (Influenza)
01/2013 - 03/2009
3Infections
01/2022 - 03/2009
2Hepatocellular Carcinoma (Hepatoma)
12/2017 - 01/2012
2Prostatic Neoplasms (Prostate Cancer)
12/2014 - 07/2013
2Breast Neoplasms (Breast Cancer)
02/2013 - 08/2008
1Cross Infection (Nosocomial Infection)
01/2022
1Influenza in Birds (Avian Flu)
01/2020
1Inflammation (Inflammations)
12/2017
1Bacterial Infections (Bacterial Infection)
01/2017
1Communicable Diseases (Infectious Diseases)
08/2013
1Lewis Lung Carcinoma
08/2013
1Chronic Hepatitis B
01/2012
1Chronic Hepatitis C
01/2012

Drug/Important Bio-Agent (IBA)

8Polysaccharides (Glycans)IBA
01/2022 - 08/2008
6VaccinesIBA
01/2022 - 02/2013
5CarbohydratesIBA
01/2022 - 08/2008
5Globo-HIBA
01/2022 - 08/2008
5AntibodiesIBA
12/2014 - 08/2008
4EpitopesIBA
01/2022 - 08/2008
4Hemagglutinins (Hemagglutinin)IBA
01/2020 - 03/2009
3Cancer VaccinesIBA
01/2022 - 02/2013
2AntigensIBA
01/2022 - 07/2013
2GlycoconjugatesIBA
01/2022 - 01/2017
2Immune Sera (Antisera)IBA
01/2022 - 08/2013
2FucoseIBA
12/2017 - 08/2013
2Complement System Proteins (Complement)IBA
12/2014 - 07/2013
2Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
01/2012 - 08/2008
1AzidesIBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1LactamsIBA
01/2022
1Carbapenems (Carbapenem Antibiotics)IBA
01/2022
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2020
1EnzymesIBA
12/2017
1Guanosine Diphosphate Fucose (GDP Fucose)IBA
12/2017
1Immunoglobulin M (IgM)IBA
08/2013
1Galactose (Galactopyranose)FDA LinkGeneric
08/2013
1GalactosamineIBA
08/2013
1Mannose (D-Mannose)IBA
08/2013
1Neoplasm Antigens (Tumor Antigens)IBA
08/2013
1Thomsen-Friedenreich antigenIBA
08/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2013
1Xylose (D-Xylose)FDA Link
08/2013
1Stage-Specific Embryonic AntigensIBA
02/2013
1GlycolipidsIBA
02/2013
1Galactosylceramides (Galactocerebrosides)IBA
02/2013
1Immunoglobulin G (IgG)IBA
02/2013
1GalNAc- 1- 3- (Fuc- 1- 2)Gal- 1- 3- GlcNAc- 1- 3- Gal- 1- 4- Glc- PAIBA
02/2013
1saponin QA-21V1 (QS21)IBA
02/2013
1Oseltamivir (Tamiflu)FDA Link
01/2013
1Zanamivir (Relenza)FDA Link
01/2013
1Neuraminidase (Sialidase)IBA
01/2013
1disialosyl galactosyl globosideIBA
01/2012
1fucosyl GM1 gangliosideIBA
01/2012
1Biomarkers (Surrogate Marker)IBA
01/2012
1DNA VaccinesIBA
03/2011
1SugarsIBA
03/2011
1OligosaccharidesIBA
10/2010
1Sialic AcidsIBA
03/2009

Therapy/Procedure

1Therapeutics
08/2008